GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » PharmaEngine Inc (ROCO:4162) » Definitions » Shiller PE Ratio

PharmaEngine (ROCO:4162) Shiller PE Ratio : 22.15 (As of May. 06, 2025)


View and export this data going back to 2012. Start your Free Trial

What is PharmaEngine Shiller PE Ratio?

As of today (2025-05-06), PharmaEngine's current share price is NT$87.70. PharmaEngine's E10 for the quarter that ended in Dec. 2024 was NT$3.96. PharmaEngine's Shiller PE Ratio for today is 22.15.

The historical rank and industry rank for PharmaEngine's Shiller PE Ratio or its related term are showing as below:

ROCO:4162' s Shiller PE Ratio Range Over the Past 10 Years
Min: 21.21   Med: 34.66   Max: 62.79
Current: 22.64

During the past years, PharmaEngine's highest Shiller PE Ratio was 62.79. The lowest was 21.21. And the median was 34.66.

ROCO:4162's Shiller PE Ratio is ranked better than
70.07% of 147 companies
in the Biotechnology industry
Industry Median: 32.73 vs ROCO:4162: 22.64

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years.

PharmaEngine's adjusted earnings per share data for the three months ended in Dec. 2024 was NT$9.860. Add all the adjusted EPS for the past 10 years together and divide 10 will get our E10, which is NT$3.96 for the trailing ten years ended in Dec. 2024.

Shiller PE for Stocks: The True Measure of Stock Valuation


PharmaEngine Shiller PE Ratio Historical Data

The historical data trend for PharmaEngine's Shiller PE Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

PharmaEngine Shiller PE Ratio Chart

PharmaEngine Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Shiller PE Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 29.32 34.96 52.40 38.05 22.79

PharmaEngine Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Shiller PE Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 38.05 34.38 32.05 30.41 22.79

Competitive Comparison of PharmaEngine's Shiller PE Ratio

For the Biotechnology subindustry, PharmaEngine's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


PharmaEngine's Shiller PE Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, PharmaEngine's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where PharmaEngine's Shiller PE Ratio falls into.


;
;

PharmaEngine Shiller PE Ratio Calculation

For Shiller PE Ratio, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller PE Ratio is also called PE10.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.

PharmaEngine's Shiller PE Ratio for today is calculated as

Shiller PE Ratio=Share Price/ E10
=87.70/3.96
=22.15

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

PharmaEngine's E10 for the quarter that ended in Dec. 2024 is calculated as:

For example, PharmaEngine's adjusted earnings per share data for the three months ended in Dec. 2024 was:

Adj_EPS=Earnings per Share (Diluted)/CPI of Dec. 2024 (Change)*Current CPI (Dec. 2024)
=9.86/133.1571*133.1571
=9.860

Current CPI (Dec. 2024) = 133.1571.

PharmaEngine Quarterly Data

Earnings per Share (Diluted) CPI Adj_EPS
201503 -0.222 99.621 -0.297
201506 2.854 100.684 3.774
201509 0.233 100.392 0.309
201512 -0.208 99.792 -0.278
201603 -0.350 100.470 -0.464
201606 1.692 101.688 2.216
201609 -0.620 101.861 -0.810
201612 4.190 101.863 5.477
201703 -0.850 102.862 -1.100
201706 -0.240 103.349 -0.309
201709 -0.020 104.136 -0.026
201712 3.740 104.011 4.788
201803 -0.330 105.290 -0.417
201806 0.480 106.317 0.601
201809 0.500 106.507 0.625
201812 0.230 105.998 0.289
201903 0.190 107.251 0.236
201906 0.200 108.070 0.246
201909 0.160 108.329 0.197
201912 -0.260 108.420 -0.319
202003 0.340 108.902 0.416
202006 0.010 108.767 0.012
202009 0.130 109.815 0.158
202012 3.580 109.897 4.338
202103 0.520 111.754 0.620
202106 1.140 114.631 1.324
202109 0.510 115.734 0.587
202112 0.770 117.630 0.872
202203 0.680 121.301 0.746
202206 0.560 125.017 0.596
202209 0.610 125.227 0.649
202212 0.370 125.222 0.393
202303 0.570 127.348 0.596
202306 0.520 128.729 0.538
202309 0.560 129.860 0.574
202312 0.260 129.419 0.268
202403 0.570 131.776 0.576
202406 1.110 132.554 1.115
202409 0.640 133.029 0.641
202412 9.860 133.157 9.860

Add all the adjusted EPS together and divide 10 will get our E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


PharmaEngine  (ROCO:4162) Shiller PE Ratio Explanation

Compared with the regular PE Ratio, which works poorly for cyclical businesses, the Shiller PE Ratio smoothed out the fluctuations of profit margins during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Shiller PE Ratio should give similar results to regular PE Ratio.

Compared with the PS Ratio, the Shiller PE Ratio makes the comparison between different industries more meaningful.


Be Aware

Shiller PE Ratio assumes that over the long term, businesses and profitability revert to their means. If a company's business model does not work in the future compared with the past, Shiller PE Ratio and PS Ratio will give false valuations.


PharmaEngine Shiller PE Ratio Related Terms

Thank you for viewing the detailed overview of PharmaEngine's Shiller PE Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


PharmaEngine Business Description

Traded in Other Exchanges
N/A
Address
10 Minsheng East Road, 11th Floor, Section 3, Taipei, TWN, 104
PharmaEngine Inc is a biopharmaceutical company engaged in the development of new drugs and therapeutic drugs for cancer. It is a specialty pharma company that adopts the no research, development-only model and the networked pharma model for new drug development. Its projects pipeline are: ONIVYDE was approved by the U.S. FDA, Taiwan FDA, and EMA for patients with gemcitabine-treated metastatic pancreatic cancer; and PEP07. It generates the revenue from Sales of goods.

PharmaEngine Headlines

No Headlines